Hexosaminidase A deficiency is an uncommon cause of a syndrome mimicking amyotrophic lateral sclerosis

被引:16
作者
Drory, VE
Birnbaum, M
Peleg, L
Goldman, B
Korczyn, AD
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Neurol & ALS Clin, IL-64239 Tel Aviv, Israel
[2] Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, Tel Aviv, Israel
关键词
amyotrophic lateral sclerosis; gene mutations; GM2; gangliosidosis; hexosaminidase A; motor neuron disease;
D O I
10.1002/mus.10371
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients with adult hexosaminidase A (Hex A) deficiency may have clinical manifestations similar to amyotrophic lateral sclerosis (AILS). Mutations in the hexosaminidase A (HEXA) gene are common in the Jewish Ashkenazi population in Israel. Serum samples of 115 Israeli patients with sporadic ALS were screened for enzymatic activity to detect "enzyme-based carriers." Fifteen samples with low (< 50%) enzymatic activity were subjected to mutation analysis, which included the two common mutations in the HEXA gene among Ashkenazi Jews (+ 1278TATC and IVS12 + 1 G-->C). Three "enzymatic carrier" patients of Moroccan origin were checked for two additional mutations (DeltaF304/305 and Arg170-->Gln), specific to this ethnic group. Two "enzymatic carrier" patients of Iraqi origin were analyzed for the mutation Gly250-->Val, specific to this population. The mutation Gly 269-->Ser was screened in carriers of Ashkenazi origin only (n = 10). The only abnormalities found were heterozygous + 1278TATC mutations in two Ashkenazi patients. Their clinical presentation was not different from that usually encountered in ALS. The frequency of mutations in the HEXA gene among Israeli ALS patients was not higher than in the healthy Israeli population. Therefore, Hex A deficiency seems to be a very unlikely cause of an ALS-mimic syndrome.
引用
收藏
页码:109 / 112
页数:4
相关论文
共 26 条
[1]  
BELSH JM, 1997, 8 INT S ALS MND GLAS
[2]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299
[3]  
DRUCKER L, 1992, AM J HUM GENET, V51, P371
[4]  
Gravel RA., 1995, The metabolic and molecular bases of inherited disease, V7th, P2839
[5]   HEXOSAMINIDASE A ACTIVITY AND AMYOTROPHIC LATERAL SCLEROSIS [J].
GUDESBLATT, M ;
LUDMAN, MD ;
COHEN, JA ;
DESNICK, RJ ;
CHESTER, S ;
GRABOWSKI, GA ;
CAROSCIO, JT .
MUSCLE & NERVE, 1988, 11 (03) :227-230
[6]   ADULT ONSET SUPRANUCLEAR OPHTHALMOPLEGIA, CEREBELLAR-ATAXIA, AND NEUROGENIC PROXIMAL MUSCLE WEAKNESS IN A BROTHER AND SISTER - ANOTHER HEXOSAMINIDASE-A DEFICIENCY SYNDROME [J].
HARDING, AE ;
YOUNG, EP ;
SCHON, F .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (06) :687-690
[7]   PARKINSONISM IN ADULT-ONSET GM2 GANGLIOSIDOSIS [J].
INZELBERG, R ;
KORCZYN, AD .
MOVEMENT DISORDERS, 1994, 9 (03) :375-377
[8]   JUVENILE SPINAL MUSCULAR-ATROPHY - A NEW HEXOSAMINIDASE DEFICIENCY PHENOTYPE [J].
JOHNSON, WG ;
WIGGER, HJ ;
KARP, HR ;
GLAUBIGER, LM ;
ROWLAND, LP .
ANNALS OF NEUROLOGY, 1982, 11 (01) :11-16
[9]   TAY-SACHS-DISEASE - CARRIER SCREENING, PRENATAL-DIAGNOSIS, AND THE MOLECULAR ERA - AN INTERNATIONAL PERSPECTIVE, 1970 TO 1993 [J].
KABACK, M ;
LIMSTEELE, J ;
DABHOLKAR, D ;
BROWN, D ;
LEVY, N ;
ZEIGER, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (19) :2307-2315
[10]   CHANGES IN THE INCIDENCE OF AMYOTROPHIC LATERAL SCLEROSIS IN ISRAEL [J].
KAHANA, E ;
ZILBER, N .
ARCHIVES OF NEUROLOGY, 1984, 41 (02) :157-160